IMA Life, a global leader in aseptic processing and freeze-drying solutions, is proud to support Sharp Sterile Manufacturing as part of its recent $28 million expansion of the Lee, Massachusetts facility. This strategic investment includes the installation of a fully automated IMA Life isolated filling line for Ready-To-Use vials, marking a significant milestone in advancing sterile manufacturing capabilities in the U.S.
The new system integrates cutting-edge robotics, non-destructive weight checks, and a state-of-the-art lyophilizer, enabling Sharp Sterile to efficiently produce batches of up to 100,000 units. By more than doubling the site’s filling capacity, this technology will help pharmaceutical partners accelerate the delivery of critical therapies to patients worldwide.
About Sharp Sterile Manufacturing
Sharp is a leader in commercial packaging, clinical services & sterile manufacturing. Sharp Sterile Manufacturing (formerly Berkshire Sterile Manufacturing) provides sterile manufacturing services with the highest level of sterility assurance and quality achievable through the use of the most modern technologies for sterile manufacturing, stringent quality standards and highly trained employees. Sharp Sterile also provides ancillary support to their clients’ drug productions such as analytical method development and validation, stability studies and formulation scale up.
For more information on Sharp Sterile Manufacturing and its solutions, please visit: www.sharpservices.com or follow us on LinkedIn
This collaboration reflects IMA Life’s commitment to providing innovative, reliable solutions that meet the highest regulatory standards for sterile drug manufacturing. Our advanced technologies are designed to ensure maximum quality, safety, and efficiency, supporting our partners in addressing the growing demand for U.S.-based aseptic fill-finish services.
Michele Arduini, IMA Life Managing Director, said: “We are delighted to contribute to Sharp Sterile Manufacturing’s expansion with our latest aseptic filling solutions. This project demonstrates how innovation and partnership can drive excellence in pharmaceutical manufacturing and ultimately benefit patients globally.”
IMA Life continues to lead the way in aseptic processing and freeze-drying technologies, offering tailored solutions to meet the evolving needs of the pharmaceutical industry.
About IMA Life
IMA Life, part of the IMA Group, is a leading provider of advanced aseptic processing and freeze-drying solutions for the pharmaceutical sector. The company’s comprehensive range of products and services supports pharmaceutical companies in achieving high-quality, efficient, and reliable manufacturing processes on a global scale. With decades of expertise, IMA Life remains at the forefront of innovation in pharmaceutical production, offering tailored solutions that meet the unique needs of each client.
For more information about IMA Life solutions, please visit: https://ima.it/pharma/brands/ima-life/ or contact us at marketing.life.it@ima.it
